Mather Charles E Iv - Net Worth and Insider Trading
Mather Charles E Iv Net Worth
The estimated net worth of Mather Charles E Iv is at least $39,447 dollars as of 2024-09-19. Mather Charles E Iv is the Director of Eyenovia Inc and owns about 77,544 shares of Eyenovia Inc (EYEN) stock worth over $39,447. Mather Charles E Iv is also the Director of Tonix Pharmaceuticals Holding Corp and owns about 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Mather Charles E Iv's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mather Charles E Iv has not made any transactions after 2023-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mather Charles E Iv
Mather Charles E Iv Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mather Charles E Iv owns 2 companies in total, including Eyenovia Inc (EYEN) , and Tonix Pharmaceuticals Holding Corp (TNXP) .
Click here to see the complete history of Mather Charles E Iv’s form 4 insider trades.
Insider Ownership Summary of Mather Charles E Iv
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYEN | Eyenovia Inc | 2023-05-26 | director |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2015-03-10 | director |
Mather Charles E Iv Latest Holdings Summary
Mather Charles E Iv currently owns a total of 2 stocks. Among these stocks, Mather Charles E Iv owns 77,544 shares of Eyenovia Inc (EYEN) as of May 26, 2023, with a value of $39,447 and a weighting of 100%. Mather Charles E Iv also owns 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of March 10, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Mather Charles E Iv
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYEN | Eyenovia Inc | 2023-05-26 | 77,544 | 0.51 | 39,447 |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2015-03-10 | 0 | 0.15 | 0 |
Holding Weightings of Mather Charles E Iv
Mather Charles E Iv Form 4 Trading Tracker
According to the SEC Form 4 filings, Mather Charles E Iv has made a total of 5 transactions in Eyenovia Inc (EYEN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Eyenovia Inc is the acquisition of 3,000 shares on May 26, 2023, which cost Mather Charles E Iv around $7,470.
According to the SEC Form 4 filings, Mather Charles E Iv has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on March 10, 2015, which cost Mather Charles E Iv around $6,800.
Insider Trading History of Mather Charles E Iv
- 1
Mather Charles E Iv Trading Performance
GuruFocus tracks the stock performance after each of Mather Charles E Iv's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mather Charles E Iv is 34.31%. GuruFocus also compares Mather Charles E Iv's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mather Charles E Iv within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mather Charles E Iv's insider trading performs compared to the benchmark.
Performance of Mather Charles E Iv
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.46 | | | | | |
| Relative Return to S&P 500(%) | -6.06 | | | | | |
Mather Charles E Iv Ownership Network
Mather Charles E Iv Owned Company Details
What does Eyenovia Inc do?
Who are the key executives at Eyenovia Inc?
Mather Charles E Iv is the director of Eyenovia Inc. Other key executives at Eyenovia Inc include director & Chief Executive Officer Michael M Rowe , 10 percent owner Stuart M. Grant , and Chief Financial Officer John P Gandolfo .
Eyenovia Inc (EYEN) Insider Trades Summary
Over the past 18 months, Mather Charles E Iv made 2 insider transaction in Eyenovia Inc (EYEN) with a net purchase of 7,000. Other recent insider transactions involving Eyenovia Inc (EYEN) include a net purchase of 1,839,115 shares made by Stuart M. Grant , a net sale of 270,000 shares made by Tsontcho Ianchulev , and a net purchase of 84,498 shares made by Michael M Rowe .
In summary, during the past 3 months, insiders sold 0 shares of Eyenovia Inc (EYEN) in total and bought 1,592,222 shares, with a net purchase of 1,592,222 shares. During the past 18 months, 270,000 shares of Eyenovia Inc (EYEN) were sold and 1,949,933 shares were bought by its insiders, resulting in a net purchase of 1,679,933 shares.
Eyenovia Inc (EYEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eyenovia Inc Insider Transactions
Mather Charles E Iv Mailing Address
Above is the net worth, insider trading, and ownership report for Mather Charles E Iv. You might contact Mather Charles E Iv via mailing address: C/o Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Suite 306, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
